TSH Biopharm Corporation Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 109.62 million compared to TWD 105.29 million a year ago. Net income was TWD 16.28 million compared to TWD 13.04 million a year ago. Basic earnings per share from continuing operations was TWD 0.42 compared to TWD 0.34 a year ago. Diluted earnings per share from continuing operations was TWD 0.42 compared to TWD 0.34 a year ago.
For the six months, sales was TWD 230.07 million compared to TWD 207.04 million a year ago. Net income was TWD 35.7 million compared to TWD 22.73 million a year ago. Basic earnings per share from continuing operations was TWD 0.93 compared to TWD 0.59 a year ago. Diluted earnings per share from continuing operations was TWD 0.93 compared to TWD 0.59 a year ago.